Climb Bio (CLYM) director Breanna Maurine Celebi files initial Form 3

Rhea-AI Filing Summary

Climb Bio, Inc. director Breanna Maurine Celebi has filed an initial Form 3, which is a required statement of beneficial ownership for new insiders. This filing lists her as a director of the company but does not report any share transactions or existing holdings at this time.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/01/2026 - 04:25 PM Accepted by SEC EDGAR 07/01/2026 - 04:25 PM Learn about SEC filing dates

FAQ

What does the Climb Bio (CLYM) Form 3 filing for Breanna Maurine Celebi show?

The Form 3 shows that Breanna Maurine Celebi is a director of Climb Bio, Inc. It is an initial statement of beneficial ownership and reports no share transactions or existing holdings for her at this time.

Did Breanna Maurine Celebi buy or sell any CLYM shares in this Form 3?

No, this Form 3 reports no share purchases or sales. The transaction summary shows zero buy, sell, exercise, gift, tax withholding, or restructuring transactions, indicating only an initial ownership status filing.

Does the Climb Bio (CLYM) Form 3 disclose any current holdings for Breanna Maurine Celebi?

The Form 3 does not disclose any current holdings for Breanna Maurine Celebi. The filing’s transaction and derivative summaries are all zero, indicating no reported positions in Climb Bio securities in this document.

What is the purpose of Breanna Maurine Celebi’s Form 3 for Climb Bio (CLYM)?

The purpose is to provide an initial statement of beneficial ownership after Breanna Maurine Celebi became a director. It fulfills SEC disclosure requirements for insiders, even though no specific share positions or transactions are reported here.

Does the Climb Bio (CLYM) Form 3 mention any derivative securities for Breanna Maurine Celebi?

No, the filing lists no derivative securities. The derivativeSummary is empty and derivativeTransactionCount is zero, indicating no options, warrants, or other derivatives reported for her in this Form 3.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Celebi Breanna Maurine

(Last) (First) (Middle)

C/O CLIMB BIO, INC.

20 WILLIAM STREET, SUITE 145

(Street)

WELLESLEY HILLS MASSACHUSETTS 02481

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2026

3. Issuer Name and Ticker or Trading Symbol
Climb Bio, Inc. [ CLYM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit Index: 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Chandra Adams, as Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)